Skip to main content
    C

    Codexis Inc (CDXS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.36
    +0.07 (+5.43%)

    Market Cap: $141.26M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    51%(20/39)
    Avg Surprise
    +18.49%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.10
    Range$-0.11 - $-0.08
    2 analysts
    EPS RevisionsNo revisions (7d)
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.09-11.8%
    60d ago$-0.09-11.8%
    30d ago$-0.08-18.8%
    7d ago$-0.08-18.8%
    Current$-0.10
    Revenue Consensus
    $19M
    Range$15M - $21M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.10
    Range$-0.11 - $-0.10
    2 analysts
    Revenue Consensus
    $27M
    Range$25M - $29M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.10---
    Sep 26EST
    		-$-0.10---
    Jun 26
    Reported Aug 11
    		$-0.13$-0.17+23.53%Beat+18.8%
    Mar 26
    Reported May 7
    		$-0.10$-0.10+0.00%Beat+60.0%
    Dec 25
    Reported Mar 11
    		$0.14$-0.04+485.44%Beat+210.0%
    Sep 25
    Reported Nov 6
    		$-0.22$-0.13-69.23%Miss+24.1%
    Jun 25
    Reported Aug 13
    		$-0.16$-0.15-6.67%Miss+50.0%
    Mar 25
    Reported May 14
    		$-0.25$-0.21-19.05%Miss-56.3%
    Dec 24
    Reported Feb 27
    		$-0.13$-0.04-225.00%Miss-30.0%
    Sep 24
    Reported Oct 31
    		$-0.29$-0.21-38.10%Miss+6.5%
    Jun 24
    Reported Aug 8
    		$-0.32$-0.24-33.33%Miss-88.2%
    Mar 24
    Reported May 2
    		$-0.16$-0.14-14.29%Miss+52.9%
    Dec 23
    Reported Feb 28
    		$-0.10$-0.12+16.67%Beat+28.6%
    Sep 23
    Reported Nov 2
    		$-0.31$-0.26-19.23%Miss-106.7%
    Jun 23
    Reported Aug 3
    		$-0.17$-0.14-21.43%Miss-325.0%
    Mar 23
    Reported May 4
    		$-0.34$-0.25-36.00%Miss-161.5%
    Dec 22
    Reported Feb 23
    		$-0.14$-0.23+39.13%Beat+12.5%
    Sep 22
    Reported Nov 3
    		$-0.15$-0.16+6.25%Beat-600.0%
    Jun 22
    Reported Aug 4
    		$-0.04N/A+66.67%Beat-300.0%
    Mar 22
    Reported May 5
    		$-0.13$-0.15+13.33%Beat-44.4%
    Dec 21
    Reported Feb 24
    		$-0.16$-0.22+27.27%Beat-166.7%
    Sep 21
    Reported Nov 4
    		$0.03$-0.05+160.00%Beat+150.0%
    Jun 21
    Reported Aug 5
    		$-0.01N/A+91.67%Beat+85.7%
    Mar 21
    Reported May 6
    		$-0.09$-0.18+50.00%Beat+30.8%
    Dec 20
    Reported Feb 25
    		$-0.06$-0.12+50.00%Beat-400.0%
    Sep 20
    Reported Nov 5
    		$-0.06$-0.05-20.00%Miss-250.0%
    Jun 20
    Reported Aug 6
    		$-0.07$-0.13+46.15%Beat+12.5%
    Mar 20
    Reported May 7
    		$-0.13$-0.15+13.33%Beat-160.0%
    Dec 19
    Reported Feb 27
    		$0.02N/A-60.00%Miss+300.0%
    Sep 19
    Reported Nov 5
    		$0.04$-0.05+180.00%Beat+200.0%
    Jun 19
    Reported Aug 6
    		$-0.08$-0.07-14.29%Miss-300.0%
    Mar 19
    Reported May 6
    		$-0.05$-0.08+37.50%Beat+0.0%
    Dec 18
    Reported Feb 26
    		$-0.01N/A+66.67%Beat-150.0%
    Sep 18
    Reported Nov 8
    		$-0.04$-0.03-33.33%Miss+81.0%
    Jun 18
    Reported Aug 8
    		$-0.02N/A+75.00%Beat+84.6%
    Mar 18
    Reported May 10
    		$-0.05$-0.08+37.50%Beat+72.2%
    Dec 17
    Reported Mar 8
    		$0.02N/A-60.00%Miss+115.4%
    Sep 17
    Reported Nov 9
    		$-0.21$-0.15-40.00%Miss-
    Jun 17
    Reported Aug 9
    		$-0.13$-0.12-8.33%Miss-
    Mar 17
    Reported May 9
    		$-0.18$-0.14-28.57%Miss-
    Dec 16
    Reported Mar 9
    		$-0.13$-0.11-18.18%Miss-

    Key Metrics

    Valuation
    P/E Ratio-4.43EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-39.60%Operating Margin-75.30%
    ROE-69.40%ROICN/A
    Financial Health
    Debt/Equity2.20xInterest CoverageN/A
    Current Ratio3.06xQuick Ratio2.99x
    Trading Statistics
    Beta2.55Avg Volume885.75K
    52-Week High$2.9852-Week Low$0.96

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.37
    SMA 20$1.37
    SMA 50$1.46
    SMA 200$1.84
    EMA 10$1.36
    EMA 20$1.38
    EMA 50$1.51
    EMA 200$1.86

    MACD

    Line: -0.04Signal: -0.04Hist: 0.01

    ADX

    ADX: 31.8+DI: 8.5-DI: 17.3

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down100.0
    PSAR$1.43

    Bollinger Bands

    Upper Band$1.43
    Lower Band$1.30
    %B Position912%(Upper)
    Band Width0.45

    RSI (14-Day)

    Neutral
    46.0

    Momentum Oscillators

    Stoch %K25.1
    Stoch %D36.8
    Williams %R-47.0
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)-144.8
    MFI (14d)54.2

    Volatility Measures

    ATR (14d)$0.08(6.2%)
    StdDev (20d)0.03
    Hist Vol47.9%(High)

    Volume Flow

    VWAP$1.33
    OBV42.3M
    AD Line-65.3M
    CMF (20d)-0.053

    Volume Metrics

    Avg Vol (20d)867.5K
    Vol Ratio0.8x
    VWMA (20d)$1.37

    Pivot Points

    R3$1.40
    R2$1.37
    R1$1.33
    Pivot Point$1.30
    S1$1.26
    S2$1.23
    S3$1.19

    Advanced Oscillators

    TSI-13.52
    Ultimate Osc55.9
    KST-72.48

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$14.91M$15.25M$38.91M$8.60M$15.33M$7.54M$21.46M$12.83M$7.98M$17.07M$26.56M$9.28M
    Cost of Revenue$3.51M$2.06M$3.36M$2.46M$2.10M$2.73M$3.65M$4.32M$3.46M$4.86M$2.86M$2.25M
    Gross Profit$11.40M$13.18M$35.55M$6.14M$13.23M$4.81M$17.81M$8.52M$4.52M$12.22M$23.70M$7.03M
    Operating Expenses$22.63M$21.23M$21.59M$25.09M$26.09M$25.30M$25.15M$25.07M$27.25M$24.11M$23.42M$39.09M
    R&D$11.71M$11.45M$10.92M$13.87M$13.78M$12.94M$12.10M$11.51M$11.41M$11.25M$11.23M$13.66M
    SG&A$10.93M$9.78M$11.19M$11.22M$12.32M$12.36M$13.05M$13.57M$15.67M$12.86M$12.18M$12.30M
    Operating Income$-11,229,000$-8,043,000$13.96M$-18,949,000$-12,862,000$-20,486,000$-7,342,000$-16,557,000$-22,732,000$-11,888,000$282,000$-32,060,000
    Interest Income$535,000$665,000$656,000$634,000$584,000$751,000$940,000$849,000$972,000$909,000$906,000$1.06M
    Interest Expense$766,000$625,000$1.59M$658,000$400,000$191,000$3.03M$4.07M$13,000$0$7.44M$2.84M
    Income Before Tax$-11,995,000$-8,668,000$9.62M$-19,607,000$-13,262,000$-20,677,000$-10,372,000$-20,630,000$-22,745,000$-11,495,000$-7,157,000$-34,899,000
    Income Tax Expense$10,000$36,000$18,000$8,000$10,000$11,000$4,000$10,000$10,000$10,000$35,000$9,000
    Net Income$-12,005,000$-8,704,000$9.60M$-19,615,000$-13,272,000$-20,688,000$-10,376,000$-20,640,000$-22,755,000$-11,505,000$-7,192,000$-34,908,000
    EBITDA$-11,157,000$-7,909,000$11.84M$-18,862,000$-12,482,000$-20,282,000$-10,200,000$-20,514,000$-22,636,000$-11,111,000$-6,847,000$-35,955,000
    EBIT$-12,530,000$-9,333,000$9.62M$-20,241,000$-13,846,000$-21,428,000$-11,312,000$-21,479,000$-23,717,000$-12,404,000$-8,063,000$-35,955,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CDXS

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    0
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Codexis Inc (4QK.DU) interactive stock chart

    This page provides an interactive stock chart for Codexis Inc (4QK.DU), traded on the Dusseldorf exchange. It displays the current stock price, recent performance (+4.01%), and links to financial summaries...

    Yahoo Finance Australia•10/15/26•Neutral

    Codexis CFO Georgia Erbez sells $8,619 of common stock

    Codexis CFO Georgia Erbez recently sold 6,335 shares of company common stock for $8,619 to cover tax obligations related to restricted stock units. Following this transaction...

    Investing.com•10/15/26•Neutral

    Form 4 Codexis Inc: Georgia Erbez (Officer) For: 12 October By Investing.com

    This article reports on a Form 4 filing for Codexis Inc., indicating that officer Georgia Erbez made a transaction on October 12th. The article is brief and primarily serves as a notification of this insider trading...

    Investing.com Canada•10/14/26•Neutral

    Form 4 Codexis Inc: Alison Moore (Director, President and CEO) For: 12 October

    This article reports on a Form 4 filing for Codexis Inc, indicating that Alison Moore, who serves as a Director, President, and CEO...

    Investing.com Nigeria•10/14/26•Neutral

    President and CEO Alison Moore sells $8,619 in Codexis stock By Investing.com

    Alison Moore, President and CEO of Codexis Inc., sold 6,335 shares of the company's common stock for approximately $8,619 to cover tax obligations related to vested Restricted Stock Units. Despite this sale...

    Investing.com Nigeria•10/14/26•Somewhat-Bullish

    CDXS Valuation and Fair Value

    P/E
    -4.4x
    Forward P/E
    149.3x
    PEG
    13.5x
    P/B
    3.8x
    See GNG's fair value

    CDXS Profitability: Margins, ROIC and FCF

    Operating margin
    -75.3%
    Net margin
    -39.6%
    ROE
    -69.4%

    CDXS Competitors

    CompanyTicker
    Nakamoto Inc.NAKA
    Molecular Partners AG ADRMOLN
    Repro Med Systems IncKRMD
    Atrium Therapeutics, Inc. Common StockRNA
    Cardiol Therapeutics Inc Class ACRDL
    Anavex Life Sciences CorpAVXL
    Neuronetics IncSTIM
    Owlet IncOWLT

    Sector: Healthcare

    CDXS Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    1
    Buy
    4
    Hold
    2
    Sell
    0
    Strong Sell
    0

    CDXS Bull Case vs Bear Case

    Bull case

    • 71.4% of CDXS's analyst ratings are Buy or Strong Buy.

    Bear case

    • CDXS has a -39.6% net profit margin.
    • CDXS beat EPS estimates in 25.0% of its last 8 reported quarters.
    • CDXS's quarterly revenue changed -2.7% year over year.

    CDXS Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    18.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.10
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About CDXS

    Does CDXS pay dividends?

    Codexis Inc (CDXS) does not currently pay a regular dividend.

    What is CDXS's market cap?

    Codexis Inc (CDXS) has a market capitalization of $141.26M with a current stock price of $1.36.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In